{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T01:51:47Z","timestamp":1778118707350,"version":"3.51.4"},"reference-count":63,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T00:00:00Z","timestamp":1653868800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Sexually transmitted infections (STI) constitute a major share of the diseases encountered by physicians. Although science has made considerable progress in terms of diagnosing and treating such infections, development of effective and safe vaccines is still needed. Syphilis, viral warts, gonorrhoea, genital herpes, chlamydia and trichomoniasis are the most common infections that are transmitted sexually. In this review, we have attempted to summarize the current status, lacunae and avenues for future research, with reference to the development of STI vaccines.<\/jats:p>","DOI":"10.1111\/ced.15223","type":"journal-article","created":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T11:24:43Z","timestamp":1650021883000},"page":"1454-1463","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Vaccines against sexually transmitted infections: an update"],"prefix":"10.1093","volume":"47","author":[{"given":"Farhat","family":"Fatima","sequence":"first","affiliation":[{"name":"Department of Dermatology Venereology, and Leprosy, Medical College & Hospital Kolkata India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satarupa","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Dermatology Venereology, and Leprosy, Medical College & Hospital Kolkata India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0841-9597","authenticated-orcid":false,"given":"Anupam","family":"Das","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology, and Leprosy KPC Medical College & Hospital Kolkata India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,8,1]]},"reference":[{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"548","DOI":"10.2471\/BLT.18.228486","article-title":"Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016","volume":"97","author":"Rowley","year":"2019","journal-title":"Bull World Health Organ"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2471\/BLT.19.237149","article-title":"Herpes simplex virus: global infection prevalence and incidence estimates, 2016","volume":"98","author":"James","year":"2020","journal-title":"Bull World Health Organ"},{"key":"2023041114210617500_","volume-title":"Report on global sexually transmitted infection surveillance 2018. WHO","author":"World Health Organization"},{"key":"2023041114210617500_","volume-title":"Global health sector strategy on sexually transmitted infections 2016\u201321. Towards ending STIs","author":"World Health Organization","year":"2016"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"F12","DOI":"10.1016\/j.vaccine.2012.07.055","article-title":"Global burden of human papillomavirus and related diseases","volume":"30","author":"Formana","year":"2012","journal-title":"Vaccine"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.1016\/j.vaccine.2017.05.069","article-title":"Human papillomavirus vaccines: WHO position paper, May 2017 \u2013 recommendations","volume":"35","author":"World Health Organization","year":"2017","journal-title":"Vaccine"},{"key":"2023041114210617500_","first-page":"399","article-title":"Update on the new 9-valent vaccine for human papillomavirus prevention","volume":"62","author":"Yang","year":"2016","journal-title":"Can Fam Physician"},{"key":"2023041114210617500_","author":"Centers for Disease Control and Prevention"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.vaccine.2021.11.062","article-title":"Human papillomavirus vaccines effectiveness to prevent genital warts: a population-based study using health system integrated databases, 2009-17","volume":"40","author":"Mu\u00f1oz-Quiles","year":"2022","journal-title":"Vaccine"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"S367","DOI":"10.1093\/infdis\/jiaa621","article-title":"Human papillomavirus vaccines","volume":"224","author":"Markowitz","year":"2021","journal-title":"J Infect Dis"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pvr.2017.12.006","article-title":"Therapeutic vaccines for high-risk HPV-associated diseases","volume":"5","author":"Chabeda","year":"2018","journal-title":"Papillomavirus Res"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/1715163515570111","article-title":"Gonorrhea: treatment update for an increasingly resistant organism","volume":"148","author":"Piszczek","year":"2015","journal-title":"Can Pharm J"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"e25355","DOI":"10.1002\/jia2.25355","article-title":"Sexually transmitted infections and HIV in the era of antiretroviral treatment and prevention: the biologic basis for epidemiologic synergy","volume":"22","author":"Cohen","year":"2019","journal-title":"J Int AIDS Soc"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1097\/OLQ.0b013e3181812d15","article-title":"The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis","volume":"35","author":"Johnson","year":"2008","journal-title":"Sex Transm Dis"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13756-017-0208-x","article-title":"The threat of antimicrobial resistance in developing countries: causes and control strategies","volume":"6","author":"Ayukekbong","year":"2017","journal-title":"Antimicrob Resist Infect Control"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13756-020-00805-7","article-title":"Azithromycin resistant gonococci: a literature review","volume":"9","author":"Derbie","year":"2020","journal-title":"Antimicrob Resist Infect Control"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1016\/j.vaccine.2020.02.073","article-title":"Gonococcal vaccines: public health value and preferred product characteristics; report of a WHO global stakeholder consultation, January 2019","volume":"38","author":"Gottlieb","year":"2020","journal-title":"Vaccine"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(17)31449-6","article-title":"Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study","volume":"390","author":"Petousis-Harris","year":"2017","journal-title":"Lancet"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/14760584.2017.1308828","article-title":"Emerging experience with meningococcal serogroup B protein vaccines","volume":"16","author":"Toneatto","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"e1008602","DOI":"10.1371\/journal.ppat.1008602","article-title":"The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae","volume":"16","author":"Leduc","year":"2020","journal-title":"PLoS Pathog"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/cid\/ciy1061","article-title":"The serogroup B meningococcal vaccine Bexsero elicits antibodies to Neisseria gonorrhoeae","volume":"69","author":"Semchenko","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1080\/21645515.2020.1827614","article-title":"Evaluating the effectiveness of the 4CMenB vaccine against invasive meningococcal disease and gonorrhoea in an infant, child and adolescent program: protocol","volume":"17","author":"Marshall","year":"2021","journal-title":"Hum Vaccines Immunother"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"e0211720","DOI":"10.1371\/journal.pone.0211720","article-title":"Global burden of maternal and congenital syphilis and associated adverse birth outcomes \u2013 estimates for 2016 and progress since 2012","volume":"14","author":"Korenromp","year":"2019","journal-title":"PLoS One"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1128\/CMR.19.1.29-49.2006","article-title":"Biological basis for syphilis","volume":"19","author":"LaFond","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.4049\/jimmunol.99.5.1012","article-title":"Immunity in experimental syphilis. V. The immunogenicity of Treponema pallidum attenuated by gamma-irradiation","volume":"99","author":"Miller","year":"1967","journal-title":"J Immunol"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"5605","DOI":"10.1128\/IAI.71.10.5605-5612.2003","article-title":"Protection against syphilis correlates with specificity of antibodies to the variable regions of Treponema pallidum repeat protein K","volume":"71","author":"Morgan","year":"2003","journal-title":"Infect Immun"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1128\/IAI.73.6.3817-3822.2005","article-title":"Immunological evaluation and cellular location analysis of the TprI antigen of Treponema pallidum subsp. pallidum","volume":"73","author":"Giacani","year":"2005","journal-title":"Infect Immun"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.micinf.2004.04.001","article-title":"Subfamily I Treponema pallidum repeat protein family: sequence variation and immunity","volume":"6","author":"Sun","year":"2004","journal-title":"Microbes Infect"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1097\/OLQ.0000000000000831","article-title":"Syphilis vaccine development: requirements, challenges, and opportunities","volume":"45","author":"Cameron","year":"2018","journal-title":"Sex Transm Dis"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"14273","DOI":"10.1038\/ncomms14273","article-title":"A defined syphilis vaccine candidate inhibits dissemination of Treponema pallidum subspecies pallidum","volume":"8","author":"Lithgow","year":"2017","journal-title":"Nat Commun"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"759474","DOI":"10.3389\/fimmu.2021.759474","article-title":"Two potential syphilis vaccine candidates inhibit dissemination of Treponema pallidum","volume":"12","author":"Xu","year":"2021","journal-title":"Front Immunol"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"e001875","DOI":"10.1136\/bmjgh-2019-001875","article-title":"The global and regional burden of genital ulcer disease due to herpes simplex virus: a natural history modelling study","volume":"5","author":"Looker","year":"2020","journal-title":"BMJ Glob Health"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-0032-1332802","article-title":"Maternal and neonatal herpes simplex virus infections","volume":"30","author":"Pinninti","year":"2013","journal-title":"Am J Perinatol"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/01.aids.0000198081.09337.a7","article-title":"Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies","volume":"20","author":"Freeman","year":"2006","journal-title":"AIDS"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/OLQ.0000000000000522","article-title":"Herpes simplex virus type 1 shedding in tears and nasal and oral mucosa of healthy adults","volume":"43","author":"Ramchandani","year":"2016","journal-title":"Sex Transm Dis"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1080\/14760584.2021.1960162","article-title":"Current vaccine approaches and emerging strategies against herpes simplex virus (HSV)","volume":"20","author":"Wijesinghe","year":"2021","journal-title":"Expert Rev Vaccines"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/infdis\/jiz225","article-title":"A randomized, double-blinded, placebo-controlled, phase 1 study of a replication-defective herpes simplex virus (HSV) type 2 vaccine, HSV529, in adults with or without HSV infection","volume":"220","author":"Dropulic","year":"2019","journal-title":"J Infect Dis"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/infdis\/jix004","article-title":"Therapeutic vaccine for genital herpes simplex virus-2 infection: findings from a randomized trial","volume":"215","author":"Bernstein","year":"2017","journal-title":"J Infect Dis"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"8520","DOI":"10.1016\/j.vaccine.2011.09.046","article-title":"Safety and immunogenicity of long HSV-2 peptides complexed with rhHsc70 in HSV-2 seropositive persons","volume":"29","author":"Wald","year":"2011","journal-title":"Vaccine"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.trsl.2021.12.006","article-title":"An mRNA vaccine to prevent genital herpes","volume":"242","author":"Awasthi","year":"2022","journal-title":"Transl Res"},{"key":"2023041114210617500_","author":"World Health Organization."},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1186\/s12879-020-05307-w","article-title":"Prevalence of genital Chlamydia trachomatis infection in the general population: a meta-analysis","volume":"20","author":"Huai","year":"2020","journal-title":"BMC Infect Dis"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20220","article-title":"The natural history of Chlamydia trachomatis infection in women: a multiparameter evidence synthesis","volume":"20","author":"Price","year":"2016","journal-title":"Health Technol Assess"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.4049\/jimmunol.180.5.3375","article-title":"Antigen-specific CD4+ T cells produce sufficient IFN-gamma to mediate robust protective immunity against genital Chlamydia muridarum infection","volume":"180","author":"Li","year":"2008","journal-title":"J Immunol"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"aaa8205","DOI":"10.1126\/science.aaa8205","article-title":"Vaccines. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells","volume":"348","author":"Stary","year":"2015","journal-title":"Science"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"963513","DOI":"10.1155\/2011\/963513","article-title":"Chlamydia trachomatis vaccine research through the years","volume":"2011","author":"Schautteet","year":"2011","journal-title":"Infect Dis Obstet Gynecol"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/QCO.0000000000000343","article-title":"Future prospects for new vaccines against sexually transmitted infections","volume":"30","author":"Gottlieb","year":"2017","journal-title":"Curr Opin Infect Dis"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.4049\/jimmunol.180.4.2459","article-title":"Immunoproteomic discovery of novel T cell antigens from the obligate intracellular pathogen Chlamydia","volume":"180","author":"Karunakaran","year":"2008","journal-title":"J Immunol"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1128\/IAI.01280-06","article-title":"Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production","volume":"75","author":"Murthy","year":"2007","journal-title":"Infect Immun"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1128\/iai.65.8.3361-3369.1997","article-title":"Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge","volume":"65","author":"Pal","year":"1997","journal-title":"Infect Immun"},{"key":"2023041114210617500_","first-page":"188","article-title":"Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine","volume":"40","author":"Ifere","year":"2007","journal-title":"J Microbiol Immunol Infect"},{"key":"2023041114210617500_","volume-title":"2020. Four curable sexually transmitted infections still affect millions worldwide","author":"World Health Organization"},{"key":"2023041114210617500_","first-page":"321","article-title":"Immunology of trichomonads, with emphasis on Trichomonas vaginalis: a review","volume":"30","author":"Honigberg","year":"1987","journal-title":"Acta Univ Carol Biol"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1128\/CMR.17.4.783-793.2004","article-title":"Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis","volume":"17","author":"Cudmore","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jiph.2010.01.003","article-title":"Prevention or treatment: the benefits of Trichomonas vaginalis vaccine","volume":"3","author":"Cudmore","year":"2010","journal-title":"J Infect Public Health"},{"key":"2023041114210617500_","first-page":"13","article-title":"Immunological and therapeutic investigations into vaginal trichomoniasis","volume":"7","author":"Aburel","year":"1963","journal-title":"Rom Med Rev"},{"key":"2023041114210617500_","first-page":"107","article-title":"Immunotherapeutic effect of the lactobacillus vaccine, Solco Trichovac, in trichomoniasis is not mediated by antibodies cross reacting with Trichomonas vaginalis","volume":"62","author":"Gombosov\u00e1","year":"1986","journal-title":"Genitourin Med"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/infdis\/jiv036","article-title":"Trichomonas vaginalis infection induces vaginal CD4 cell infiltration in a mouse model: a vaccine strategy to reduce vaginal infection and HIV transmission","volume":"212","author":"Smith","year":"2015","journal-title":"J Infect Dis"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.ijpara.2005.08.010","article-title":"Intranasal immunisation with a 62 kDa proteinase combined with cholera toxin or CpG adjuvant protects against Trichomonas vaginalis genital tract infections in mice","volume":"35","author":"Hern\u00e1ndez","year":"2005","journal-title":"Int J Parasitol"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13071-017-2009-8","article-title":"Recombinant \u03b1-actinin subunit antigens of Trichomonas vaginalis as potential vaccine candidates in protecting against trichomoniasis","volume":"10","author":"Xie","year":"2017","journal-title":"Parasites Vectors"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"Rerks-Ngarm","year":"2009","journal-title":"N Engl J Med"},{"key":"2023041114210617500_","doi-asserted-by":"crossref","first-page":"590780","DOI":"10.3389\/fimmu.2020.590780","article-title":"Major scientific hurdles in HIV vaccine development: historical perspective and future directions","volume":"11","author":"Ng'uni","year":"2020","journal-title":"Front Immunol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ced.15223","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ced.15223","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/47\/8\/1454\/49838740\/ced1454.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/47\/8\/1454\/49838740\/ced1454.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T01:48:01Z","timestamp":1700444881000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/47\/8\/1454\/6692912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,1]]},"references-count":63,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8,1]]},"published-print":{"date-parts":[[2022,8,1]]}},"URL":"https:\/\/doi.org\/10.1111\/ced.15223","relation":{},"ISSN":["1365-2230","0307-6938"],"issn-type":[{"value":"1365-2230","type":"electronic"},{"value":"0307-6938","type":"print"}],"subject":[],"published-other":{"date-parts":[[2022,8,1]]},"published":{"date-parts":[[2022,8,1]]},"assertion":[{"value":"2022-04-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}